Cost-effectiveness of Sacubitril/Valsartan in acute and chronic heart failure with reduced ejection fraction: from randomized controlled trials to real-world evidence
Event:
Heart Failure 2023
Topic:
Pharmacotherapy
Session:
ePosters in acute heart failure 7
